<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Hansa Biopharma — Januar 2024]]></title><description><![CDATA[<p dir="auto">Hansa Biopharma provides update on business and key financials ahead of the JP Morgan Healthcare Conference</p>
<p dir="auto"><div class="card col-md-9 col-lg-6 position-relative link-preview p-0">



<a href="https://news.cision.com/hansa-biopharma-ab/r/hansa-biopharma-provides-update-on-business-and-key-financials-ahead-of-the-jp-morgan-healthcare-con,c3904989" title="Hansa Biopharma provides update on business and key financials ahead of the JP Morgan Healthcare Conference">
<img src="https://mb.cision.com/Public/1219/logo/961eb95ced00be7f_org.png" class="card-img-top not-responsive" style="max-height: 15rem;" alt="Link Preview Image" onerror="this.parentElement.remove()" />
</a>







<div class="card-body">
<h5 class="card-title">
<a class="text-decoration-none" href="https://news.cision.com/hansa-biopharma-ab/r/hansa-biopharma-provides-update-on-business-and-key-financials-ahead-of-the-jp-morgan-healthcare-con,c3904989">
Hansa Biopharma provides update on business and key financials ahead of the JP Morgan Healthcare Conference
</a>
</h5>
<p class="card-text line-clamp-3">· Strong revenue generation in Q4 2023, including SEK 43m in Idefirix® product sales supported by</p>
</div>
<a href="https://news.cision.com/hansa-biopharma-ab/r/hansa-biopharma-provides-update-on-business-and-key-financials-ahead-of-the-jp-morgan-healthcare-con,c3904989" class="card-footer text-body-secondary small d-flex gap-2 align-items-center lh-2">



<img src="https://news.cision.com/favicon.ico" alt="favicon" class="not-responsive overflow-hiddden" style="max-width: 21px; max-height: 21px;" onerror="this.remove()"/>



<p class="d-inline-block text-truncate mb-0">News Powered by Cision <span class="text-secondary">(news.cision.com)</span></p>
</a>
</div></p>
]]></description><link>https://dev.proinvestor.com/forum/topic/400746/hansa-biopharma-januar-2024</link><generator>RSS for Node</generator><lastBuildDate>Sat, 06 Jun 2026 05:21:39 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/400746.rss" rel="self" type="application/rss+xml"/><pubDate>Sat, 06 Jan 2024 13:42:36 GMT</pubDate><ttl>60</ttl><item><title><![CDATA[Reply to Hansa Biopharma — Januar 2024 on Wed, 31 Jan 2024 05:37:13 GMT]]></title><description><![CDATA[<p dir="auto">God morgen <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=ace6278a214" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8007192</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8007192</guid><dc:creator><![CDATA[LP90]]></dc:creator><pubDate>Wed, 31 Jan 2024 05:37:13 GMT</pubDate></item><item><title><![CDATA[Reply to Hansa Biopharma — Januar 2024 on Tue, 30 Jan 2024 05:19:16 GMT]]></title><description><![CDATA[<p dir="auto">Godmorgen <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=ace6278a214" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /> fint løft Sarepta gav kursen lad det forsætte lang lang vej endnu</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8007189</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8007189</guid><dc:creator><![CDATA[LP90]]></dc:creator><pubDate>Tue, 30 Jan 2024 05:19:16 GMT</pubDate></item><item><title><![CDATA[Reply to Hansa Biopharma — Januar 2024 on Tue, 30 Jan 2024 05:18:44 GMT]]></title><description><![CDATA[<p dir="auto">Måske mere en indirekte kurspåvirkning - altså det er jo positivt at det går godt for partneren Sarepta Sarepta Therapeutics ...</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8007191</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8007191</guid><dc:creator><![CDATA[exitnu]]></dc:creator><pubDate>Tue, 30 Jan 2024 05:18:44 GMT</pubDate></item><item><title><![CDATA[Reply to Hansa Biopharma — Januar 2024 on Tue, 30 Jan 2024 05:14:27 GMT]]></title><description><![CDATA[<p dir="auto">God morgen <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=ace6278a214" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8007187</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8007187</guid><dc:creator><![CDATA[exitnu]]></dc:creator><pubDate>Tue, 30 Jan 2024 05:14:27 GMT</pubDate></item><item><title><![CDATA[Reply to Hansa Biopharma — Januar 2024 on Mon, 29 Jan 2024 15:14:40 GMT]]></title><description><![CDATA[<p dir="auto">Sarepta Therapeutics Announces Positive Data from Part B of MOMENTUM, a Phase 2 Study of SRP-5051 in Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 51</p>
<p dir="auto"><a href="https://investorrelations.sarepta.com/news-releases/news-release-details/sarepta-therapeutics-announces-positive-data-part-b-momentum" rel="nofollow ugc">https://investorrelations.sarepta.com/news-releases/news-release-details/sarepta-therapeutics-announces-positive-data-part-b-momentum</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8007190</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8007190</guid><dc:creator><![CDATA[exitnu]]></dc:creator><pubDate>Mon, 29 Jan 2024 15:14:40 GMT</pubDate></item><item><title><![CDATA[Reply to Hansa Biopharma — Januar 2024 on Mon, 29 Jan 2024 14:00:47 GMT]]></title><description><![CDATA[<p dir="auto">Lidt udsving idag!</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8007185</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8007185</guid><dc:creator><![CDATA[exitnu]]></dc:creator><pubDate>Mon, 29 Jan 2024 14:00:47 GMT</pubDate></item><item><title><![CDATA[Reply to Hansa Biopharma — Januar 2024 on Mon, 29 Jan 2024 09:11:04 GMT]]></title><description><![CDATA[<p dir="auto">Ungeee ja men Zealand gør det til stort set dagskursen alle andre og jeg har mange der har lavet de sidste 14 mdr. har de gjort det til langt langt langt under kursen senest eks virogates-Xbrane<br />
osv. osv. og så blive du rundbarberet men dejligt for nye at de kan komme ind til en slik men for os der har støttet igennem 4-5 år vi bliver banket total i gulvet</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8007184</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8007184</guid><dc:creator><![CDATA[LP90]]></dc:creator><pubDate>Mon, 29 Jan 2024 09:11:04 GMT</pubDate></item><item><title><![CDATA[Reply to Hansa Biopharma — Januar 2024 on Mon, 29 Jan 2024 06:45:31 GMT]]></title><description><![CDATA[<p dir="auto">Det tror jeg der gør. Synes tit man ser offentliggørelse af positive resultater inden en emission. Men på den lange bare er en emission positivt - se bare alle de gange ZEAL har solgt nye aktier. Det afgørende er om de får skabt et produkt. Det er heller ikke vigtigt om ledelsen køber op og sender signaler nu, hvis de positive ting alligevel først kommer om nogle år.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8007183</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8007183</guid><dc:creator><![CDATA[ungeee]]></dc:creator><pubDate>Mon, 29 Jan 2024 06:45:31 GMT</pubDate></item><item><title><![CDATA[Reply to Hansa Biopharma — Januar 2024 on Mon, 29 Jan 2024 05:32:01 GMT]]></title><description><![CDATA[<p dir="auto">Godmorgen <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=ace6278a214" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /> håber godt nok ikke de kommer med en emission her i forbindelse med regnskabet vil være en katastrofe få nu gang i salget og samarbejdsaftaler og få penge ind den vej kursen tåler ikke en emission</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8007180</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8007180</guid><dc:creator><![CDATA[LP90]]></dc:creator><pubDate>Mon, 29 Jan 2024 05:32:01 GMT</pubDate></item><item><title><![CDATA[Reply to Hansa Biopharma — Januar 2024 on Fri, 26 Jan 2024 12:07:41 GMT]]></title><description><![CDATA[<p dir="auto">Bestemt ganske prisværdigt ...</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8007188</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8007188</guid><dc:creator><![CDATA[exitnu]]></dc:creator><pubDate>Fri, 26 Jan 2024 12:07:41 GMT</pubDate></item><item><title><![CDATA[Reply to Hansa Biopharma — Januar 2024 on Fri, 26 Jan 2024 05:49:54 GMT]]></title><description><![CDATA[<p dir="auto">Godmorgen <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=ace6278a214" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8007193</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8007193</guid><dc:creator><![CDATA[LP90]]></dc:creator><pubDate>Fri, 26 Jan 2024 05:49:54 GMT</pubDate></item><item><title><![CDATA[Reply to Hansa Biopharma — Januar 2024 on Thu, 25 Jan 2024 14:34:06 GMT]]></title><description><![CDATA[<p dir="auto">sygdom er noget frygtlig noget så derfor er 90 % af min portefølje i forsøg på at knække koderne på alle mulige sygdomme og hvert år til landsindsamlingen knæk cancer popper jeg op på tv med et pænt stort beløb som jeg donerer til det gode formål <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=ace6278a214" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8007186</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8007186</guid><dc:creator><![CDATA[LP90]]></dc:creator><pubDate>Thu, 25 Jan 2024 14:34:06 GMT</pubDate></item><item><title><![CDATA[Reply to Hansa Biopharma — Januar 2024 on Thu, 25 Jan 2024 14:30:53 GMT]]></title><description><![CDATA[<p dir="auto">exitnu ja den har jeg også forholdsvis mange af solgt lidt på den hurtige stigning i dag men har stadig mange <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=ace6278a214" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /> du kan nok ikke nævne nogle aktier jeg ikke har jeg har alt alt for mange af de farlige i medico/biotek/pharma <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=ace6278a214" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8007178</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8007178</guid><dc:creator><![CDATA[LP90]]></dc:creator><pubDate>Thu, 25 Jan 2024 14:30:53 GMT</pubDate></item><item><title><![CDATA[Reply to Hansa Biopharma — Januar 2024 on Thu, 25 Jan 2024 10:00:01 GMT]]></title><description><![CDATA[<p dir="auto">Ok, men pludselig kan det jo også vende - se fx Ascelia Pharma <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=ace6278a214" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8007177</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8007177</guid><dc:creator><![CDATA[exitnu]]></dc:creator><pubDate>Thu, 25 Jan 2024 10:00:01 GMT</pubDate></item><item><title><![CDATA[Reply to Hansa Biopharma — Januar 2024 on Thu, 25 Jan 2024 09:08:56 GMT]]></title><description><![CDATA[<p dir="auto">exitnu føler mig bondefanget i de 2 cases</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8007181</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8007181</guid><dc:creator><![CDATA[LP90]]></dc:creator><pubDate>Thu, 25 Jan 2024 09:08:56 GMT</pubDate></item><item><title><![CDATA[Reply to Hansa Biopharma — Januar 2024 on Thu, 25 Jan 2024 06:49:15 GMT]]></title><description><![CDATA[<p dir="auto"><a class="plugin-mentions-user plugin-mentions-a" href="/forum/user/lp90" aria-label="Profile: LP90">@<bdi>LP90</bdi></a> - ang. Xbrane &amp; "massivt i begge" - vil du forsvarer din position?</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8007179</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8007179</guid><dc:creator><![CDATA[exitnu]]></dc:creator><pubDate>Thu, 25 Jan 2024 06:49:15 GMT</pubDate></item><item><title><![CDATA[Reply to Hansa Biopharma — Januar 2024 on Thu, 25 Jan 2024 05:43:58 GMT]]></title><description><![CDATA[<p dir="auto">desværre er jeg massivt i begge aktier de havde så lys en fremtid med unikke produkter men ekstremt dårlig ledet virksomheder gør vi står sådan her</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8007173</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8007173</guid><dc:creator><![CDATA[LP90]]></dc:creator><pubDate>Thu, 25 Jan 2024 05:43:58 GMT</pubDate></item><item><title><![CDATA[Reply to Hansa Biopharma — Januar 2024 on Thu, 25 Jan 2024 05:42:41 GMT]]></title><description><![CDATA[<p dir="auto">Godmorgen <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=ace6278a214" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /> ja trist de ikke har formået at generer et større salg løbende de har været så langsomme og uprofessionelle med salgsdelen derfor står de hvor de står og Xbrane en trist eksempel på dårlig ledelse lidt samme historie for lidt salg dårlig ledelse og kæmpe pengeafbrænding på forkerte ting og mistede aftaler osv.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8007174</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8007174</guid><dc:creator><![CDATA[LP90]]></dc:creator><pubDate>Thu, 25 Jan 2024 05:42:41 GMT</pubDate></item><item><title><![CDATA[Reply to Hansa Biopharma — Januar 2024 on Wed, 24 Jan 2024 13:29:08 GMT]]></title><description><![CDATA[<p dir="auto">Investorerne er afventende. Hansa brænder kontanter af hver dag. Mit bud er at der kommer en kapitaludvidelse indenfor 0-6 måneder, og at det kommer til at ligge i størrelseorden 5-800 mio. SEK. Nok til at dække min. 1 års forbrug. Kapitaludvidelser er bare gift for biotek for øjeblikket. Især i selskaber hvor der ikke er tillid og fremdrift. Seneste eksempel på hvor dårligt det kan times er Xbrane, uden sammenligning i øvrigt. Jeg kigger tidligst på HANSA igen ifb med en kapitaludvidelse.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8007172</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8007172</guid><dc:creator><![CDATA[radar24]]></dc:creator><pubDate>Wed, 24 Jan 2024 13:29:08 GMT</pubDate></item><item><title><![CDATA[Reply to Hansa Biopharma — Januar 2024 on Wed, 24 Jan 2024 05:40:46 GMT]]></title><description><![CDATA[<p dir="auto">God morgen <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=ace6278a214" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8007171</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8007171</guid><dc:creator><![CDATA[LP90]]></dc:creator><pubDate>Wed, 24 Jan 2024 05:40:46 GMT</pubDate></item><item><title><![CDATA[Reply to Hansa Biopharma — Januar 2024 on Tue, 23 Jan 2024 05:48:16 GMT]]></title><description><![CDATA[<p dir="auto">Morning <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=ace6278a214" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /> så siver aktien stille og roligt ned igen sku ikke den store tillid investorerne har til casen og det er forståeligt nok</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8007175</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8007175</guid><dc:creator><![CDATA[LP90]]></dc:creator><pubDate>Tue, 23 Jan 2024 05:48:16 GMT</pubDate></item><item><title><![CDATA[Reply to Hansa Biopharma — Januar 2024 on Mon, 22 Jan 2024 05:43:39 GMT]]></title><description><![CDATA[<p dir="auto">Godmorgen <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=ace6278a214" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8007167</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8007167</guid><dc:creator><![CDATA[LP90]]></dc:creator><pubDate>Mon, 22 Jan 2024 05:43:39 GMT</pubDate></item><item><title><![CDATA[Reply to Hansa Biopharma — Januar 2024 on Fri, 19 Jan 2024 05:35:33 GMT]]></title><description><![CDATA[<p dir="auto">God morgen <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=ace6278a214" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8007182</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8007182</guid><dc:creator><![CDATA[LP90]]></dc:creator><pubDate>Fri, 19 Jan 2024 05:35:33 GMT</pubDate></item><item><title><![CDATA[Reply to Hansa Biopharma — Januar 2024 on Thu, 18 Jan 2024 05:23:55 GMT]]></title><description><![CDATA[<p dir="auto">Morning <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=ace6278a214" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8007166</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8007166</guid><dc:creator><![CDATA[LP90]]></dc:creator><pubDate>Thu, 18 Jan 2024 05:23:55 GMT</pubDate></item></channel></rss>